MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ALKS — Alkermes Inc. plc
NasdaqAlkermes Inc. plc
$40.54
+0.02(+0.05%)
- O
- 40.00
- H
- 41.41
- L
- 39.99
- V
- 2.28M
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About ALKS
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 16, 1991
Employees2,050
Stock ExchangeNasdaq
Ticker SymbolALKS
Websitehttps://www.alkermes.com
Key Financial Statistics
| Market Cap | $6.85B |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.94 - $98.50 |
| 52-Week Avg Volume | 1.02M |
| VWAP | $40.68 |
| Transactions | 27,421 |
| Total Recorded Bars | 8,866 days |